From estrogen to androgen receptor: A new pathway for sex hormones in prostate

Shuyuan Yeh, Hiroshi Miyamoto, Hiroki Shima, Chawnshang Chang

Research output: Contribution to journalArticlepeer-review

Abstract

While all three coactivators ARA70, steroid receptor coactivator 1, and RAC3/ACTR can enhance androgen receptor (AR) transcriptional activity at 1 nM dihydrotestosterone, we here demonstrate that only ARA70 can induce AR transcriptional activity >30-fold in the presence of 10 nM 17β-estradiol (E2), but not diethylstilbestrol. The significance of this newly described E2-induced AR transcriptional activity in DU145 human prostate cancer cells was further strengthened by finding patients with Reifenstein partial- androgen-insensitive syndrome that fail in the E2-AR-ARA70 pathway. Together, our data suggest, for the first time, testosterone/dihydrotestosterone may not be the only ligands for the AR. E2 represents another important natural ligand for AR that may play an essential role for the AR function and the development of the male reproductive system.

Original languageEnglish (US)
Pages (from-to)5527-5532
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number10
DOIs
StatePublished - May 12 1998

Keywords

  • ACTR
  • ARA70
  • Androgen receptor coactivator
  • RAC3
  • SRC-1

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'From estrogen to androgen receptor: A new pathway for sex hormones in prostate'. Together they form a unique fingerprint.

Cite this